all - Opinion Summaries

IGEN v. ROCHE DIAGNOSTICS GMBH

Contracts, Drugs & Biotech
In a breach of contract action, summary judgement and denial of judgment as a matter of law on claims for unfair competition and breach of the implied...

ABBOTT LABS v. BAXTER PHARM. PROS., INC.

Drugs & Biotech, Intellectual Property, Patent
Because the district court erred in construing the asserted claims directed to compositions and methods of preventing the degradation of sevoflurane...

ELI LILLY & CO. v. BD. OF REGENTS OF THE UNIV. OF WASHINGTON

Drugs & Biotech, Intellectual Property, Patent
Because the Director of the PTO's interpretation of 37 C.F.R. section 1.601(n) as establishing a "two-way" test for determining whether two parties...

BD. OF EDUC. v. AM. BIOSCIENCE, INC.

Drugs & Biotech, Intellectual Property, Patent
In an inventorship action related to a chemotherapeutic agent, the district court erred in its determination of inventorship as to the true and...

COOK INC. v. BOSTON SCIENTIFIC CORP.

Contracts, Drugs & Biotech, Intellectual Property, Patent
The district judge did not err in finding that a transaction between plaintiff and a third party was a de facto assignment under Washington law, and...

IN RE: CARDIZEM CD ANTITRUST LITIG.

Antitrust & Trade Regulation, Commercial Law, Drugs & Biotech
Once it is decided that a restraint of trade is subject to per se analysis, claimed lack of any actual anticompetitive effects or presence of...

DOW CHEM. CO. v. STEPHENSON

Drugs & Biotech, Injury & Tort Law, Military Law
In appeals arising from Agent Orange exposure, judgment as to two respondents is vacated and remanded for further consideration in light of Syngenta...

INTEGRA LIFESCIENCES I, LTD. v. MERCK KGAA

Drugs & Biotech, Intellectual Property, Patent
The district court correctly construed the claims and determined that defendant's infringing activity did not fall within the safe harbor of 35 U.S.C....

CROPLIFE AM. v. ENVTL. PROT. AGENCY

Agriculture, Drugs & Biotech, Environmental Law
An EPA directive, banning agency consideration of "third party" human studies in evaluating the safety of pesticides, constituted a binding regulation...

US v. YEAGER

Commercial Law, Criminal Law & Procedure, Drugs & Biotech, Remedies, Sentencing
Under U.S.S.G. section 2F1.1, profits obtained by the defendant from non-authorized sales are a reasonable estimate of the loss suffered when a...